Deutsche Bank’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-143,825
| Closed | -$7.55M | – | 4650 |
|
|
2020
Q3 | $7.55M | Buy |
143,825
+12,304
| +9% | +$509K | 0.01% | 1078 |
|
|
2020
Q2 | $4.38M | Buy |
131,521
+70,029
| +114% | +$2.23M | ﹤0.01% | 1372 |
|
|
2020
Q1 | $1.67M | Sell |
61,492
-111,106
| -64% | -$3.09M | ﹤0.01% | 1809 |
|
|
2019
Q4 | $3.4M | Buy |
172,598
+116,136
| +206% | +$1.86M | ﹤0.01% | 1666 |
|
|
2019
Q3 | $730K | Sell |
56,462
-9,579
| -15% | -$116K | ﹤0.01% | 2493 |
|
|
2019
Q2 | $820K | Sell |
66,041
-8,345
| -11% | -$111K | ﹤0.01% | 2977 |
|
|
2019
Q1 | $1.08M | Sell |
74,386
-21,289
| -22% | -$272K | ﹤0.01% | 2949 |
|
|
2018
Q4 | $1.05M | Sell |
95,675
-211,371
| -69% | -$2.94M | ﹤0.01% | 2848 |
|
|
2018
Q3 | $8.07M | Buy |
307,046
+3,974
| +1% | +$107K | ﹤0.01% | 1827 |
|
|
2018
Q2 | $6.2M | Buy |
303,072
+34,378
| +13% | +$738K | ﹤0.01% | 2138 |
|
|
2018
Q1 | $4.88M | Buy |
268,694
+93,874
| +54% | +$1.57M | ﹤0.01% | 2231 |
|
|
2017
Q4 | $2.44M | Buy |
174,820
+71,304
| +69% | +$964K | ﹤0.01% | 2588 |
|
|
2017
Q3 | $1.91M | Buy |
103,516
+3,396
| +3% | +$56.8K | ﹤0.01% | 2568 |
|
|
2017
Q2 | $1.69M | Buy |
100,120
+82,081
| +455% | +$1.25M | ﹤0.01% | 2674 |
|
|
2017
Q1 | $239K | Sell |
18,039
-28,756
| -61% | -$450K | ﹤0.01% | 3492 |
|
|
2016
Q4 | $703K | Sell |
46,795
-63,654
| -58% | -$841K | ﹤0.01% | 2935 |
|
|
2016
Q3 | $1.29M | Sell |
110,449
-137,560
| -55% | -$1.62M | ﹤0.01% | 2653 |
|
|
2016
Q2 | $2.68M | Sell |
248,009
-37,965
| -13% | -$392K | ﹤0.01% | 2187 |
|
|
2016
Q1 | $2.64M | Buy |
285,974
+20,138
| +8% | +$217K | ﹤0.01% | 2179 |
|
|
2015
Q4 | $3.94M | Sell |
265,836
-63,310
| -19% | -$1.06M | ﹤0.01% | 1962 |
|
|
2015
Q3 | $5.4M | Buy |
329,146
+58,939
| +22% | +$1.21M | ﹤0.01% | 1754 |
|
|
2015
Q2 | $6.16M | Buy |
270,207
+108,626
| +67% | +$2.16M | ﹤0.01% | 1659 |
|
|
2015
Q1 | $2.45M | Buy |
161,581
+60,650
| +60% | +$788K | ﹤0.01% | 2291 |
|
|
2014
Q4 | $1.21M | Sell |
100,931
-83,409
| -45% | -$953K | ﹤0.01% | 3080 |
|
|
2014
Q3 | $2.09M | Sell |
184,340
-152,376
| -45% | -$1.74M | ﹤0.01% | 2493 |
|
|
2014
Q2 | $4.07M | Sell |
336,716
-8,994
| -3% | -$106K | ﹤0.01% | 1965 |
|
|
2014
Q1 | $4.03M | Buy |
345,710
+274,598
| +386% | +$4.65M | ﹤0.01% | 1967 |
|
|
2013
Q4 | $1.26M | Sell |
71,112
-101,559
| -59% | -$1.71M | ﹤0.01% | 2527 |
|
|
2013
Q3 | $2.48M | Buy |
172,671
+27,836
| +19% | +$426K | ﹤0.01% | 2333 |
|
|
2013
Q2 | $2.18M | Buy |
+144,835
| New | +$1.91M | ﹤0.01% | 2164 |
|
Deutsche Bank's MNTA Position: Q4 2020 in Review
Deutsche Bank sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 143,825 shares — an estimated $7.55M sold.
Deutsche Bank first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $8.07M in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Deutsche Bank reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Deutsche Bank sold 143,825 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $7.55M.
- Deutsche Bank first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Deutsche Bank's Momenta Pharmaceuticals, Inc. position peaked at $8.07M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.